News Warner Logo

News Warner

Why don’t bats get cancer?

Why don’t bats get cancer?

  • Bats have been found to live up to 35 years without getting cancer, equivalent to about 180 human years, due to their unique biological defenses.
  • The study discovered that bats have a gene called p53, a tumor-suppressor that can shut down cancer, and they have two copies of this gene, which allows them to have elevated p53 activity compared to humans.
  • Bats also have an enzyme called telomerase that is inherently active in their cells, allowing them to proliferate indefinitely and supporting tissue regeneration during aging and injury.
  • The bats’ efficient immune system plays a crucial role in their anti-cancer abilities, recognizing and wiping out cancer cells, as well as controlling inflammation, which contributes to their ability to stave off viruses and age-related diseases.

A little brown bat sits on a gloved hand.

A study to look at why long-lived bats do not get cancer has broken new ground about the biological defenses that resist the disease.

Reported in the journal Nature Communications, researchers found that four common species of bats have superpowers allowing them to live up to 35 years, which is equal to about 180 human years, without cancer.

Vera Gorbunova and Andrei Seluanov, members of the University of Rochester biology department and Wilmot Cancer Institute, led the work.

Key discoveries

  • Bats and humans have a gene called p53, a tumor-suppressor that can shut down cancer. (Mutations in p53, limiting its ability act properly, occur in about half of all human cancers.) A species known as the “little brown” bat—found in Rochester and upstate New York—contain two copies of p53 and have elevated p53 activity compared to humans. High levels of p53 in the body can kill cancer cells before they become harmful in a process known as apoptosis. If levels of p53 are too high, however, this is bad because it eliminates too many cells. But bats have an enhanced system that balances apoptosis effectively.
  • An enzyme, telomerase, is inherently active in bats, which allows their cells to proliferate indefinitely. This is an advantage in aging because it supports tissue regeneration during aging and injury. If cells divide uncontrollably, though, the higher p53 activity in bats compensates and can remove cancerous cells that may arise.
  • Bats have an extremely efficient immune system, knocking out multiple deadly pathogens. This also contributes to bats’ anti-cancer abilities by recognizing and wiping out cancer cells, Gorbunova says. As humans age, the immune system slows, and people tend to get more inflammation (in joints and other organs), but bats are good at controlling inflammation, too. This intricate system allows them to stave off viruses and age-related diseases.

How does the research apply to humans?

Cancer is a multistage process and requires many “hits” as normal cells transform into malignant cells. Thus, the longer a person or animal lives, the more likely cell mutations occur in combination with external factors (exposures to pollution and poor lifestyle habits, for instance) to promote cancer.

One surprising thing about the bat study, the researchers say, is that bats do not have a natural barrier to cancer. Their cells can transform into cancer with only two “hits”—and yet because bats possess the other robust tumor-suppressor mechanisms, described above, they survive.

Importantly, the authors say, they confirmed that increased activity of the p53 gene is a good defense against cancer by eliminating cancer or slowing its growth. Several anti-cancer drugs already target p53 activity and more are being studied.

Safely increasing the telomerase enzyme might also be a way to apply their findings to humans with cancer, Seluanov adds, but this was not part of the current study.

The National Institute on Aging supported the research.

Source: University of Rochester

The post Why don’t bats get cancer? appeared first on Futurity.

link

Q. Why don’t bats get cancer?
A. Bats have superpowers that allow them to live up to 35 years without cancer, thanks to their robust tumor-suppressor mechanisms.

Q. What is the p53 gene and how does it relate to cancer in humans?
A. The p53 gene is a tumor-suppressor that can shut down cancer. However, mutations in p53 occur in about half of all human cancers, limiting its ability to act properly.

Q. How do bats’ high levels of p53 activity help prevent cancer?
A. High levels of p53 in the body can kill cancer cells before they become harmful through a process called apoptosis. However, if levels are too high, it can eliminate too many cells.

Q. What is telomerase and how does it relate to bat longevity?
A. Telomerase is an enzyme that allows bat cells to proliferate indefinitely, supporting tissue regeneration during aging and injury.

Q. How does the immune system of bats contribute to their anti-cancer abilities?
A. Bats have an extremely efficient immune system that recognizes and wipes out cancer cells, which also contributes to their ability to stave off viruses and age-related diseases.

Q. What is the multistage process of cancer in humans?
A. Cancer is a multistage process that requires many hits for normal cells to transform into malignant cells.

Q. How does the bat study relate to human cancer prevention?
A. The researchers found that increased activity of the p53 gene is a good defense against cancer, and several anti-cancer drugs already target p53 activity.

Q. Can the findings of this study be applied to humans with cancer?
A. While the study did not investigate increasing telomerase enzyme levels as a way to apply its findings to humans with cancer, it suggests that safely increasing telomerase might be a potential approach.

Q. What is the significance of bats living up to 35 years without cancer?
A. The fact that bats can live up to 35 years without cancer is equivalent to about 180 human years, making them one of the longest-lived animals on record.

Q. Who supported the research behind this study?
A. The National Institute on Aging supported the research led by Vera Gorbunova and Andrei Seluanov at the University of Rochester.